Autolus Therapeutics Ltd
AUTL
$1.61-6.40%
Delayed · as of Oct 16, 2026, 2:15 PM ET
Mkt cap
$614.78M
EV/Sales
6.77
P/E ratio
N/A
FY2025 Revenue
$75.39M
EPS (TTM)
$-1.06
Gross Margin (FY2025)
-27.83%
Profit Margin (FY2025)
-381.40%
Beta
1.74
Div yield
N/A
Sector
Healthcare
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Latest reported AUTL revenue for 2025-12-31 was $75.4M. Net income was -$287.5M. Revenue was up 644.9% from 2024-12-31 to 2025-12-31. AUTL currently screens at market cap $614.8M.
Use this AUTL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AUTL income, balance, and cash tables.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company in the Healthcare sector.
Latest cached Autolus Therapeutics Ltd (AUTL) revenue for Dec 31, 2025 was $75.4M. Net income was -$287.5M. Statements: https://lician.com/financials/autl
Autolus Therapeutics Ltd (AUTL) market capitalization is $614.8M on the latest cached snapshot.
Autolus Therapeutics Ltd (AUTL) cached previous close $1.72; day range $1.61 – $1.74; volume 1,238,452. Session quote: https://lician.com/quote/autl
Autolus Therapeutics Ltd (AUTL) latest cached earnings event is "AUTL earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AUTL filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/autl